[
  {
    "ts": "2026-02-11T00:14:00+00:00",
    "headline": "FDA Refuses to Consider Approving Use of Moderna‚Äôs New Flu Vaccine",
    "summary": "The company said the agency wouldn‚Äôt review its application on the grounds that the study testing the shot wasn‚Äôt sufficient.",
    "url": "https://www.wsj.com/health/pharma/fda-refuses-to-consider-approving-use-of-modernas-new-flu-vaccine-c1c6ea42?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b43c7075-59ff-323c-8604-31cd5dd7cc12",
      "content": {
        "id": "b43c7075-59ff-323c-8604-31cd5dd7cc12",
        "contentType": "STORY",
        "title": "FDA Refuses to Consider Approving Use of Moderna‚Äôs New Flu Vaccine",
        "description": "",
        "summary": "The company said the agency wouldn‚Äôt review its application on the grounds that the study testing the shot wasn‚Äôt sufficient.",
        "pubDate": "2026-02-11T00:14:00Z",
        "displayTime": "2026-02-11T00:14:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b43c7075-59ff-323c-8604-31cd5dd7cc12/fda-refuses-to-consider.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/d29b771b3ea5ff6f078814282f4a193c",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jM_ibhuJYVeGhUHfXS0lHw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/d29b771b3ea5ff6f078814282f4a193c.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Juooi3zHWv1vS9bsG5mi_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/d29b771b3ea5ff6f078814282f4a193c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/pharma/fda-refuses-to-consider-approving-use-of-modernas-new-flu-vaccine-c1c6ea42?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T08:38:50+00:00",
    "headline": "Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week",
    "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government closure. Another shutdown may loom if Congress doesn't reach a deal on immigration enforcement.",
    "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/cisco-earnings-jobs-report-cpi-data-still-to-come-this-week-Wn9uKjGw5zkerFJPANtH?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "2fe6bced-7ab5-36cd-badf-76c552194292",
      "content": {
        "id": "2fe6bced-7ab5-36cd-badf-76c552194292",
        "contentType": "STORY",
        "title": "Cisco Earnings, Jobs Report, CPI Data: Still to Come This Week",
        "description": "",
        "summary": "This week brings a deluge of economic indicators, particularly jobs and inflation reports, which were stalled by the recent government closure. Another shutdown may loom if Congress doesn't reach a deal on immigration enforcement.",
        "pubDate": "2026-02-11T08:38:50Z",
        "displayTime": "2026-02-11T08:38:50Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/2fe6bced-7ab5-36cd-badf-76c552194292/cisco-earnings-jobs-report-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/74Y7puEtMTJo02esBmIMTg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ng98BxS_YdX7FknFQwiRaQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/05766f3173ada94d07d55c12d565fe11.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/cisco-earnings-jobs-report-cpi-data-still-to-come-this-week-Wn9uKjGw5zkerFJPANtH?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CSCO"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "MCD"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "TMUS"
            },
            {
              "symbol": "ABNB"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "WEN"
            },
            {
              "symbol": "AMAT"
            },
            {
              "symbol": "DKNG"
            },
            {
              "symbol": "H"
            },
            {
              "symbol": "UL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T10:40:54+00:00",
    "headline": "Stocks to Watch Wednesday: Warner/Netflix, Moderna, SLB",
    "summary": "üîé Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
    "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/stocks-to-watch-wednesday-warner-netflix-moderna-slb-YzWh4VKjhc1yk5Tkqgej?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df",
      "content": {
        "id": "3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df",
        "contentType": "STORY",
        "title": "Stocks to Watch Wednesday: Warner/Netflix, Moderna, SLB",
        "description": "",
        "summary": "üîé Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
        "pubDate": "2026-02-11T10:40:54Z",
        "displayTime": "2026-02-11T10:40:54Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df/stocks-to-watch-wednesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dhXTF4wsGHfm1.G_hAN.PQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zOKgAYhUJnMhuQnNrS5kzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/stocks-to-watch-wednesday-warner-netflix-moderna-slb-YzWh4VKjhc1yk5Tkqgej?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "SLB"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "ASTS"
            },
            {
              "symbol": "HAL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T11:44:51+00:00",
    "headline": "Moderna shares fall as FDA declines to review new flu vaccine",
    "summary": "Feb 11 (Reuters) - Shares of Moderna slumped nearly 9% in premarket trading on Wednesday after the U. Food and Drug Administration declined ‚Äåto review the company's application for approval of its experimental influenza ‚Äåvaccine, underscoring shifts in U.",
    "url": "https://finance.yahoo.com/news/moderna-shares-fall-fda-declines-114451462.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "c6e4f6a9-55c5-32a1-af27-32de9bc4c350",
      "content": {
        "id": "c6e4f6a9-55c5-32a1-af27-32de9bc4c350",
        "contentType": "STORY",
        "title": "Moderna shares fall as FDA declines to review new flu vaccine",
        "description": "",
        "summary": "Feb 11 (Reuters) - Shares of Moderna slumped nearly 9% in premarket trading on Wednesday after the U. Food and Drug Administration declined ‚Äåto review the company's application for approval of its experimental influenza ‚Äåvaccine, underscoring shifts in U.",
        "pubDate": "2026-02-11T11:44:51Z",
        "displayTime": "2026-02-11T11:44:51Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/7e3c2d0021911ac9f232114c70bf075c",
          "originalWidth": 800,
          "originalHeight": 533,
          "caption": "FILE PHOTO: A sign marks the headquarters of the coronavirus disease (COVID-19) vaccine maker Moderna in Cambridge, Massachusetts, U.S., April 28, 2022. REUTERS/Brian Snyder/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/4af7IIDSIY_O3iUJ4Mt1WA--~B/aD01MzM7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/7e3c2d0021911ac9f232114c70bf075c.cf.webp",
              "width": 800,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_sZTq_Kqx0pVqRkP94U2IA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/7e3c2d0021911ac9f232114c70bf075c.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/moderna-shares-fall-fda-declines-114451462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/moderna-shares-fall-fda-declines-114451462.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T11:29:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Moderna, Robinhood, Cloudflare, Humana, Lyft, Mattel, Beta Technologies, Gilead, and More",
    "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Moderna, Robinhood, Cloudflare, Humana, Lyft, Mattel, Beta Technologies, Gilead, and More",
        "description": "",
        "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T11:29:00Z",
        "displayTime": "2026-02-11T11:29:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "NET"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "BETA"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "MSTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T13:11:59+00:00",
    "headline": "Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges",
    "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
    "url": "https://finance.yahoo.com/news/live/earnings-live-vertiv-stock-soars-on-upbeat-outlook-lyft-and-robinhood-shares-tumble-mattel-plunges-131159977.html",
    "source": "Yahoo Finance",
    "provider": "yfinance",
    "raw": {
      "id": "19cd1080-a43d-4393-8ed1-77d2b30d3322",
      "content": {
        "id": "19cd1080-a43d-4393-8ed1-77d2b30d3322",
        "contentType": "STORY",
        "title": "Earnings live: Vertiv stock soars on upbeat outlook, Lyft and Robinhood shares tumble, Mattel plunges",
        "description": "",
        "summary": "The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.",
        "pubDate": "2026-02-11T13:11:59Z",
        "displayTime": "2026-02-11T13:18:17Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-images/2019-11/99c271c0-0175-11ea-bedb-f416ac28bba4",
          "originalWidth": 6720,
          "originalHeight": 4480,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/LUpCyBrJL3fb0QlsDOpvPg--~B/aD00NDgwO3c9NjcyMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-images/2019-11/99c271c0-0175-11ea-bedb-f416ac28bba4.cf.webp",
              "width": 6720,
              "height": 4480,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mYCq6mOjAKW4NmnwXJOM_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-images/2019-11/99c271c0-0175-11ea-bedb-f416ac28bba4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance",
          "url": "http://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-vertiv-stock-soars-on-upbeat-outlook-lyft-and-robinhood-shares-tumble-mattel-plunges-131159977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/live/earnings-live-vertiv-stock-soars-on-upbeat-outlook-lyft-and-robinhood-shares-tumble-mattel-plunges-131159977.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "KO"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "F"
            },
            {
              "symbol": "RIVN"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "ABNB"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T14:44:54+00:00",
    "headline": "Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans",
    "summary": "Morning Brief Host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of the day's top trending stock tickers, including the Wall Street Journal reporting that activist investor Ancora is positioned to oppose a potential deal between Warner Bros. Discovery (WBD) and Netfix (NFLX), Kraft Heinz (KHC) putting a pause on its plans to spin-off a segment of the food company, and the US Food and Drug Administration (FDA) refusing to review Moderna's (MRNA) new flu vaccine. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
    "url": "https://finance.yahoo.com/video/ancora-oppose-wbd-netflix-deal-144454896.html",
    "source": "Yahoo Finance Video",
    "provider": "yfinance",
    "raw": {
      "id": "ecd2f769-8daa-3f6b-ac04-6150ec48b8e5",
      "content": {
        "id": "ecd2f769-8daa-3f6b-ac04-6150ec48b8e5",
        "contentType": "VIDEO",
        "title": "Ancora to oppose WBD-Netflix deal, Kraft Heinz halts split plans",
        "description": "<p>Morning Brief Host <a data-i13n=\"cpos:1;pos:1\" href=\"https://www.yahoo.com/author/julie-hyman/?.tsrc=fin-srch\">Julie Hyman</a> and Yahoo Finance Markets and Data Editor <a data-i13n=\"cpos:2;pos:1\" href=\"https://www.yahoo.com/author/jared-blikre/\">Jared Blikre</a> track several of the day's top trending stock tickers, including the <a data-i13n=\"cpos:3;pos:1\" href=\"https://www.wsj.com/business/deals/activist-investor-pushes-warner-to-walk-away-from-netflix-deal-0bbe663e?gaa_at=eafs&gaa_n=AWEtsqfH-XIS_1J2bEF7-3qqH-mHHxVq0Hg8yfPO8zomBi9mfmc1Ljga4XY1qmjJCXQ%3D&gaa_ts=698c9c66&gaa_sig=oyTUhoDwrU7IYTLubFt5IMxJdyo9tSOOZWdEY9HCfaaR9_dr1rHTRlM2-CgqaVVCJ3pt4bxltE_zhVTH2AQJKg%3D%3D\">Wall Street Journal </a>reporting that activist investor Ancora is positioned to oppose a potential deal between Warner Bros. Discovery (<a data-i13n=\"cpos:4;pos:1\" href=\"https://finance.yahoo.com/quote/WBD\">WBD</a>) and Netfix (<a data-i13n=\"cpos:5;pos:1\" href=\"https://finance.yahoo.com/quote/NFLX\">NFLX</a>), Kraft Heinz (<a data-i13n=\"cpos:6;pos:1\" href=\"https://finance.yahoo.com/quote/KHC\">KHC</a>) putting a pause on its plans to spin-off a segment of the food company, and the US Food and Drug Administration (FDA) refusing to review Moderna's (<a data-i13n=\"cpos:7;pos:1\" href=\"https://finance.yahoo.com/quote/MRNA\">MRNA</a>) new flu vaccine.</p>\n<p>To watch more expert insights and analysis on the latest market action, check out more¬†<a data-i13n=\"cpos:8;pos:1\" href=\"https://finance.yahoo.com/videos/series/morning-brief/\">Morning Brief</a>.</p>",
        "summary": "Morning Brief Host Julie Hyman and Yahoo Finance Markets and Data Editor Jared Blikre track several of the day's top trending stock tickers, including the Wall Street Journal reporting that activist investor Ancora is positioned to oppose a potential deal between Warner Bros. Discovery (WBD) and Netfix (NFLX), Kraft Heinz (KHC) putting a pause on its plans to spin-off a segment of the food company, and the US Food and Drug Administration (FDA) refusing to review Moderna's (MRNA) new flu vaccine. To watch more expert insights and analysis on the latest market action, check out more&nbsp;Morning Brief.",
        "pubDate": "2026-02-11T14:44:54Z",
        "displayTime": "",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://s.yimg.com/os/creatr-uploaded-images/2026-02/54b6b270-0755-11f1-be66-f8eafc790f96",
          "originalWidth": 5612,
          "originalHeight": 3159,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dBBxkYke7d4Y7rW2s4w_Iw--~B/aD0zMTU5O3c9NTYxMjthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/os/creatr-uploaded-images/2026-02/54b6b270-0755-11f1-be66-f8eafc790f96.cf.webp",
              "width": 5612,
              "height": 3159,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lQN9EJXW_20sSJUi0S2Z2A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://s.yimg.com/os/creatr-uploaded-images/2026-02/54b6b270-0755-11f1-be66-f8eafc790f96.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Yahoo Finance Video",
          "url": "https://finance.yahoo.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/video/ancora-oppose-wbd-netflix-deal-144454896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/video/ancora-oppose-wbd-netflix-deal-144454896.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": true
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KHC"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "WBD"
            },
            {
              "symbol": "NFLX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T13:24:00+00:00",
    "headline": "Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected.",
    "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
    "url": "https://www.barrons.com/articles/moderna-stock-price-flu-vaccine-rejected-fda-cc3ed490?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "47998de2-2525-3340-ac78-c12bd999fa77",
      "content": {
        "id": "47998de2-2525-3340-ac78-c12bd999fa77",
        "contentType": "STORY",
        "title": "Moderna Stock Sinks. The Puzzling Reason Its Flu Vaccine Was Rejected.",
        "description": "",
        "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
        "pubDate": "2026-02-11T13:24:00Z",
        "displayTime": "2026-02-11T13:24:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/47998de2-2525-3340-ac78-c12bd999fa77/moderna-stock-sinks-the.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Rg8ZjGj7ro12ZC9W6rSlDA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AhIeusGRlMgYYeJSIVMjQA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/moderna-stock-price-flu-vaccine-rejected-fda-cc3ed490?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T12:46:46+00:00",
    "headline": "Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB",
    "summary": "üîé Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
    "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/stocks-to-watch-wednesday-warner-netflix-moderna-slb-YzWh4VKjhc1yk5Tkqgej?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df",
      "content": {
        "id": "3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df",
        "contentType": "STORY",
        "title": "Stocks to Watch Wednesday: Netflix, QXO, Moderna, SLB",
        "description": "",
        "summary": "üîé Warner Bros. Discovery (WBD): Activist investor Ancora has built a roughly $200 million stake in Warner and plans to oppose its deal with Netflix (NFLX). Ancora thinks Warner failed to adequately engage with Paramount Skydance (PSKY)'s rival offer.",
        "pubDate": "2026-02-11T12:46:46Z",
        "displayTime": "2026-02-11T12:46:46Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/3418ba31-4a07-3ab4-8bf1-bc7f2a1fb3df/stocks-to-watch-wednesday-.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dhXTF4wsGHfm1.G_hAN.PQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/zOKgAYhUJnMhuQnNrS5kzA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/eb31499363a3441da4fbd4dae0616024.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/jobs-report-unemployment-stock-market-02-11-2026/card/stocks-to-watch-wednesday-warner-netflix-moderna-slb-YzWh4VKjhc1yk5Tkqgej?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "QXO"
            },
            {
              "symbol": "SLB"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "HAL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T12:41:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Moderna, Robinhood, Shopify, Kraft Heinz, Cloudflare, Humana, Lyft, Mattel, Beta Tech, and More",
    "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Moderna, Robinhood, Shopify, Kraft Heinz, Cloudflare, Humana, Lyft, Mattel, Beta Tech, and More",
        "description": "",
        "summary": "Shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T12:41:00Z",
        "displayTime": "2026-02-11T12:41:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "BETA"
            },
            {
              "symbol": "GILD"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "NET"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "MSTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T06:49:00+00:00",
    "headline": "FDA refuses to review Moderna‚Äôs mRNA flu vaccine",
    "summary": "Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was ‚Äúinconsistent‚Äù with prior FDA communications and went against the regulator‚Äôs established guidance for flu shots.",
    "url": "https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "220a37b9-3f56-3985-b64c-9638b5c6bf94",
      "content": {
        "id": "220a37b9-3f56-3985-b64c-9638b5c6bf94",
        "contentType": "STORY",
        "title": "FDA refuses to review Moderna‚Äôs mRNA flu vaccine",
        "description": "",
        "summary": "Moderna claimed that the decision, issued by top vaccine regulator Vinay Prasad, was ‚Äúinconsistent‚Äù with prior FDA communications and went against the regulator‚Äôs established guidance for flu shots.",
        "pubDate": "2026-02-11T06:49:00Z",
        "displayTime": "2026-02-11T06:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/ab17b0a3580390f16f2a51ea8e46db6b",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pA2Y6VcWA4VtkFQngSgsZg--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/ab17b0a3580390f16f2a51ea8e46db6b.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/_Dy8wPKS7DCerxa5Hc7v_w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/ab17b0a3580390f16f2a51ea8e46db6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/moderna-fda-influenza-mrna-refuse-to-file/811909/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-refuses-review-moderna-mrna-064900999.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T14:07:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Kraft Heinz, Vertiv, Unity, Cloudflare, Lyft, Mattel, and More",
    "summary": "Shopify reports better-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Kraft Heinz, Vertiv, Unity, Cloudflare, Lyft, Mattel, and More",
        "description": "",
        "summary": "Shopify reports better-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T14:07:00Z",
        "displayTime": "2026-02-11T14:07:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "BETA"
            },
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "NET"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "MSTR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T09:33:00+00:00",
    "headline": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
    "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream‚Äôs asthma results.",
    "url": "https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/",
    "source": "BioPharma Dive",
    "provider": "yfinance",
    "raw": {
      "id": "2d79906b-266e-33bb-9f2c-a672985d2183",
      "content": {
        "id": "2d79906b-266e-33bb-9f2c-a672985d2183",
        "contentType": "STORY",
        "title": "Evommune rockets on eczema data; AstraZeneca advances GLP-1 pill",
        "description": "",
        "summary": "Shares of Evommune nearly doubled on data suggesting it has a potential threat to Dupixent. Elsewhere, a closely watched narcolepsy drug got an FDA decision date and investors scrutinized Upstream‚Äôs asthma results.",
        "pubDate": "2026-02-11T09:33:00Z",
        "displayTime": "2026-02-11T09:33:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YSECyFvzK8sIEiUW4LIicA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/heEgXBvKL8Y58FXAXGaXPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/biopharma_dive_768/e36d70a3849ea73409df7aca9613c259.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "BioPharma Dive",
          "url": "https://biopharmadive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.biopharmadive.com/news/evommune-eczema-astrazeneca-obesity-upstream-takeda-oveporexton-moderna/811791/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evommune-rockets-eczema-data-astrazeneca-093300749.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EVMN"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "TAK"
            },
            {
              "symbol": "UPB"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "REGN"
            },
            {
              "symbol": "397030.KQ"
            },
            {
              "symbol": "SNY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T17:29:34+00:00",
    "headline": "Why Moderna Stock Is Sinking Today",
    "summary": "Moderna Stock Drops After FDA Rejects Flu Vaccine Filing",
    "url": "https://finance.yahoo.com/news/why-moderna-stock-sinking-today-172934083.html",
    "source": "GuruFocus.com",
    "provider": "yfinance",
    "raw": {
      "id": "ef00ee79-f0fc-3886-95c2-27e779815b9b",
      "content": {
        "id": "ef00ee79-f0fc-3886-95c2-27e779815b9b",
        "contentType": "STORY",
        "title": "Why Moderna Stock Is Sinking Today",
        "description": "",
        "summary": "Moderna Stock Drops After FDA Rejects Flu Vaccine Filing",
        "pubDate": "2026-02-11T17:29:34Z",
        "displayTime": "2026-02-11T17:29:34Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "GuruFocus.com",
          "url": "http://www.gurufocus.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-moderna-stock-sinking-today-172934083.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-moderna-stock-sinking-today-172934083.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T17:27:00+00:00",
    "headline": "Health Care Roundup: Market Talk",
    "summary": "0647 ET ‚Äì Shares in Moderna fall 8% premarket after the U.S. Food and Drug Administration refused to review the drugmaker‚Äôs application to sell a new seasonal flu vaccine.  The FDA said Moderna failed to adequately compare the vaccine to its peers, though it didn‚Äôt cite safety or efficacy issues in a letter to the company.  The FDA‚Äôs decision could also impact the pending approval of Moderna‚Äôs combined Covid-19 and flu jab, in turn weighing on the company‚Äôs 2028 cash flow, the analysts say.",
    "url": "https://www.wsj.com/health/health-care-roundup-market-talk-fe712fbd?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "0d83cd60-27d9-3143-a222-000fb1864aa7",
      "content": {
        "id": "0d83cd60-27d9-3143-a222-000fb1864aa7",
        "contentType": "STORY",
        "title": "Health Care Roundup: Market Talk",
        "description": "",
        "summary": "0647 ET ‚Äì Shares in Moderna fall 8% premarket after the U.S. Food and Drug Administration refused to review the drugmaker‚Äôs application to sell a new seasonal flu vaccine.  The FDA said Moderna failed to adequately compare the vaccine to its peers, though it didn‚Äôt cite safety or efficacy issues in a letter to the company.  The FDA‚Äôs decision could also impact the pending approval of Moderna‚Äôs combined Covid-19 and flu jab, in turn weighing on the company‚Äôs 2028 cash flow, the analysts say.",
        "pubDate": "2026-02-11T17:27:00Z",
        "displayTime": "2026-02-11T17:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/0d83cd60-27d9-3143-a222-000fb1864aa7/health-care-roundup-market.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/d4b9cc8ab27a6f941c8c817444b86244",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QMTc7YxRjXpdl0.Iy00W7A--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/d4b9cc8ab27a6f941c8c817444b86244.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/P_iO15lhT6nndmEDdwfNrg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/d4b9cc8ab27a6f941c8c817444b86244.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/health/health-care-roundup-market-talk-fe712fbd?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T17:14:54+00:00",
    "headline": "Moderna Plunges After FDA Rejects Its Messenger-RNA-Based Flu Shot",
    "summary": "The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that proved to be a blow to recently hot Moderna stock.",
    "url": "https://www.investors.com/news/technology/moderna-stock-fda-cber-mrna-based-flu-shot/?src=A00220&yptr=yahoo",
    "source": "Investor's Business Daily",
    "provider": "yfinance",
    "raw": {
      "id": "cd97bf2a-29ee-34db-b465-1aaf0fa5875d",
      "content": {
        "id": "cd97bf2a-29ee-34db-b465-1aaf0fa5875d",
        "contentType": "STORY",
        "title": "Moderna Plunges After FDA Rejects Its Messenger-RNA-Based Flu Shot",
        "description": "",
        "summary": "The FDA rejected Moderna's experimental flu vaccine Tuesday in a move that proved to be a blow to recently hot Moderna stock.",
        "pubDate": "2026-02-11T17:14:54Z",
        "displayTime": "2026-02-11T17:14:54Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/cd97bf2a-29ee-34db-b465-1aaf0fa5875d/moderna-plunges-after-fda.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/ibd.com/63bf0f266eb923d77dbe2608216fb4bd",
          "originalWidth": 945,
          "originalHeight": 533,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w92h_RmcgNt6dFvdhSjzAw--~B/aD01MzM7dz05NDU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/63bf0f266eb923d77dbe2608216fb4bd.cf.webp",
              "width": 945,
              "height": 533,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/wJyadL4qFAB0Nkjx7Gfocg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/ibd.com/63bf0f266eb923d77dbe2608216fb4bd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Investor's Business Daily",
          "url": "http://www.investors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.investors.com/news/technology/moderna-stock-fda-cber-mrna-based-flu-shot/?src=A00220&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T16:46:09+00:00",
    "headline": "FDA declines to review Moderna‚Äôs seasonal flu mRNA vaccine",
    "summary": "The FDA‚Äôs call comes within a wider push from the US government to alter vaccine policy.",
    "url": "https://www.pharmaceutical-technology.com/news/fda-declines-to-review-moderna-flu-vaccine-mrna1010/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "cfedbace-f092-3282-9e67-e047a3401ff7",
      "content": {
        "id": "cfedbace-f092-3282-9e67-e047a3401ff7",
        "contentType": "STORY",
        "title": "FDA declines to review Moderna‚Äôs seasonal flu mRNA vaccine",
        "description": "",
        "summary": "The FDA‚Äôs call comes within a wider push from the US government to alter vaccine policy.",
        "pubDate": "2026-02-11T16:46:09Z",
        "displayTime": "2026-02-11T16:46:09Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/9e33eabb9fa7b0e7019a25065d54ebb7",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "Analysts note that the FDA's refusal to review mRNA-1010 could impact Moderna's capacity to break even in 2028. Image credit: MargJohnsonVA via ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/yonq9l7FoJ8g7XMu_ciMMA--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/9e33eabb9fa7b0e7019a25065d54ebb7.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OBzmDsPPLeZkun4w8FA8Fw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/9e33eabb9fa7b0e7019a25065d54ebb7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/fda-declines-to-review-moderna-flu-vaccine-mrna1010/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-declines-review-moderna-seasonal-164609898.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T15:45:00+00:00",
    "headline": "MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA",
    "summary": "Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.",
    "url": "https://finance.yahoo.com/news/mrna-down-nearly-10-fda-154500565.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "62808657-e7c1-3437-94be-0c4df3ceb522",
      "content": {
        "id": "62808657-e7c1-3437-94be-0c4df3ceb522",
        "contentType": "STORY",
        "title": "MRNA Down Nearly 10% as FDA Refuses to Review Influenza Vaccine BLA",
        "description": "",
        "summary": "Moderna shares sink 10% after FDA issues Refusal-to-File letter for its mRNA-1010 flu vaccine, citing trial design concerns despite no safety flags.",
        "pubDate": "2026-02-11T15:45:00Z",
        "displayTime": "2026-02-11T15:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrna-down-nearly-10-fda-154500565.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrna-down-nearly-10-fda-154500565.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T15:40:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Vertiv, Unity, Zillow, Beta Tech, Lyft, Mattel, Astera, and More",
    "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Vertiv, Unity, Zillow, Beta Tech, Lyft, Mattel, Astera, and More",
        "description": "",
        "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T15:40:00Z",
        "displayTime": "2026-02-11T15:40:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "KHC"
            },
            {
              "symbol": "U"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "MAT"
            },
            {
              "symbol": "ALAB"
            },
            {
              "symbol": "BTC-USD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T18:33:36+00:00",
    "headline": "Mexico enlists Moderna to boost mRNA supply for respiratory diseases",
    "summary": "Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna‚Äôs portfolio.",
    "url": "https://www.pharmaceutical-technology.com/news/mexico-enlists-moderna-to-boost-mrna-supply-for-respiratory-diseases/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "8622eb5f-6bae-3665-ac10-682931ca877a",
      "content": {
        "id": "8622eb5f-6bae-3665-ac10-682931ca877a",
        "contentType": "STORY",
        "title": "Mexico enlists Moderna to boost mRNA supply for respiratory diseases",
        "description": "",
        "summary": "Unlike the US, Mexico is bolstering its mRNA offerings with the help of Moderna‚Äôs portfolio.",
        "pubDate": "2026-02-11T18:33:36Z",
        "displayTime": "2026-02-11T18:33:36Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/791c5e669c97ad08077bdafaaeb438ea",
          "originalWidth": 1000,
          "originalHeight": 667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/gzJF6tDXPiVyX.ltFxyiHQ--~B/aD02Njc7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/791c5e669c97ad08077bdafaaeb438ea.cf.webp",
              "width": 1000,
              "height": 667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/M2skuMEzmnZRHQ.os4CItQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/791c5e669c97ad08077bdafaaeb438ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/mexico-enlists-moderna-to-boost-mrna-supply-for-respiratory-diseases/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mexico-enlists-moderna-boost-mrna-183336541.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T18:16:00+00:00",
    "headline": "Moderna Stock Sinks on Vaccine Rejection. Company Is ‚ÄòDesperately Seeking Clarification.‚Äô",
    "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
    "url": "https://www.barrons.com/articles/moderna-stock-price-flu-vaccine-rejected-fda-cc3ed490?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "47998de2-2525-3340-ac78-c12bd999fa77",
      "content": {
        "id": "47998de2-2525-3340-ac78-c12bd999fa77",
        "contentType": "STORY",
        "title": "Moderna Stock Sinks on Vaccine Rejection. Company Is ‚ÄòDesperately Seeking Clarification.‚Äô",
        "description": "",
        "summary": "The vaccine maker says the Food and Drug Administration has refused to review its application to sell a new seasonal flu vaccine.",
        "pubDate": "2026-02-11T18:16:00Z",
        "displayTime": "2026-02-11T18:16:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/47998de2-2525-3340-ac78-c12bd999fa77/moderna-stock-sinks-on.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Rg8ZjGj7ro12ZC9W6rSlDA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AhIeusGRlMgYYeJSIVMjQA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/24ce218fac1f3446e3c135f8ba6e5163.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/moderna-stock-price-flu-vaccine-rejected-fda-cc3ed490?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T18:11:46+00:00",
    "headline": "FDA Letter Stalls Moderna Flu Filing While Stock Trades Above Targets",
    "summary": "FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy concerns. The FDA decline means the current application will not move into full review unless Moderna adjusts and resubmits. Moderna, known for its mRNA based Covid-19 vaccine, has been working to expand into seasonal respiratory vaccines, including flu. The FDA response on mRNA-1010 focuses...",
    "url": "https://finance.yahoo.com/news/fda-letter-stalls-moderna-flu-181146666.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "df9f2c1c-b958-30f8-9a70-3cdd68c2620c",
      "content": {
        "id": "df9f2c1c-b958-30f8-9a70-3cdd68c2620c",
        "contentType": "STORY",
        "title": "FDA Letter Stalls Moderna Flu Filing While Stock Trades Above Targets",
        "description": "",
        "summary": "FDA issues a Refusal to File letter to Moderna (NasdaqGS:MRNA) for its influenza vaccine candidate mRNA-1010. The decision centers on the choice of clinical trial comparator, not on safety or efficacy concerns. The FDA decline means the current application will not move into full review unless Moderna adjusts and resubmits. Moderna, known for its mRNA based Covid-19 vaccine, has been working to expand into seasonal respiratory vaccines, including flu. The FDA response on mRNA-1010 focuses...",
        "pubDate": "2026-02-11T18:11:46Z",
        "displayTime": "2026-02-11T18:11:46Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/lV6Oo0M_C3X63uXoBkpnwQ--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/KdbFtaQiMRVA6Enl712wNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/759f0ca28b885d5d534769cdaccce534.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/fda-letter-stalls-moderna-flu-181146666.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/fda-letter-stalls-moderna-flu-181146666.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T18:00:00+00:00",
    "headline": "Moderna's investigational flu vaccine denied FDA review, shares drop",
    "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration‚Äôs (FDA) Center for Biologics Evaluation and Research (CBER) has issued a Refusal-to-File (RTF) letter for the company‚Äôs biologics license application for its...",
    "url": "https://www.proactiveinvestors.com/companies/news/1087224/moderna-s-investigational-flu-vaccine-denied-fda-review-shares-drop-1087224.html",
    "source": "Proactive",
    "provider": "yfinance",
    "raw": {
      "id": "f5f0693d-3a40-358c-92fe-f16a2c4b617e",
      "content": {
        "id": "f5f0693d-3a40-358c-92fe-f16a2c4b617e",
        "contentType": "STORY",
        "title": "Moderna's investigational flu vaccine denied FDA review, shares drop",
        "description": "",
        "summary": "Moderna Inc (NASDAQ:MRNA, XETRA:0QF) shares fell almost 6% after the drugmaker announced that the US Food and Drug Administration‚Äôs (FDA) Center for Biologics Evaluation and Research (CBER) has issued a Refusal-to-File (RTF) letter for the company‚Äôs biologics license application for its...",
        "pubDate": "2026-02-11T18:00:00Z",
        "displayTime": "2026-02-11T18:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/proactive_us_504/9484ad2b3abecced8f09a53a54018fc3",
          "originalWidth": 1280,
          "originalHeight": 591,
          "caption": "Moderna's investigational flu vaccine denied FDA review, shares drop",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/CWs4kasMUMDDfRwYSsEZIw--~B/aD01OTE7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/proactive_us_504/9484ad2b3abecced8f09a53a54018fc3.cf.webp",
              "width": 1280,
              "height": 591,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GLSx8W3e0.VDnVlmav05JQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_us_504/9484ad2b3abecced8f09a53a54018fc3.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Proactive",
          "url": "https://www.proactiveinvestors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.proactiveinvestors.com/companies/news/1087224/moderna-s-investigational-flu-vaccine-denied-fda-review-shares-drop-1087224.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/modernas-investigational-flu-vaccine-denied-180000309.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T17:14:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, T-Mobile, and More",
    "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, T-Mobile, and More",
        "description": "",
        "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T17:14:00Z",
        "displayTime": "2026-02-11T17:14:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "U"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "TMUS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T20:13:50+00:00",
    "headline": "Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves",
    "summary": "We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 28, Barclays assumed coverage of Moderna, Inc. (NASDAQ:MRNA) with an Equal Weight rating and a $25 price target as part of a broader biotechnology coverage expansion. The firm expressed a constructive view on the sector heading into 2026, citing [‚Ä¶]",
    "url": "https://finance.yahoo.com/news/barclays-starts-moderna-inc-mrna-201350481.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4f63c517-1644-3a61-a227-39fde2a84844",
      "content": {
        "id": "4f63c517-1644-3a61-a227-39fde2a84844",
        "contentType": "STORY",
        "title": "Barclays Starts Moderna, Inc. (MRNA) Neutral as Biotech Outlook Improves",
        "description": "",
        "summary": "We recently published an article titled 10 Best Long Term Healthcare Stocks to Buy. On January 28, Barclays assumed coverage of Moderna, Inc. (NASDAQ:MRNA) with an Equal Weight rating and a $25 price target as part of a broader biotechnology coverage expansion. The firm expressed a constructive view on the sector heading into 2026, citing [‚Ä¶]",
        "pubDate": "2026-02-11T20:13:50Z",
        "displayTime": "2026-02-11T20:13:50Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/17463a3a6ef8a85835627df790b97d90",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vxAdLH57WfxvLwlLvlrF1A--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/17463a3a6ef8a85835627df790b97d90.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/9.Yc8TJ1KWjAAU4mhszo1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/17463a3a6ef8a85835627df790b97d90.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/barclays-starts-moderna-inc-mrna-201350481.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/barclays-starts-moderna-inc-mrna-201350481.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T19:57:00+00:00",
    "headline": "Dow still safely above 50,000 but early gains cut, Mattel and Lyft plunge",
    "summary": "There were 130k new jobs added in January, well ahead of the consensus forecast of 55k",
    "url": "https://www.proactiveinvestors.com/companies/news/1087191/nasdaq-and-dow-jones-seen-rising-ahead-of-delayed-jobs-report-1087191.html",
    "source": "Proactive",
    "provider": "yfinance",
    "raw": {
      "id": "e30577f3-5ae8-38f8-89a4-14d84dca7e93",
      "content": {
        "id": "e30577f3-5ae8-38f8-89a4-14d84dca7e93",
        "contentType": "STORY",
        "title": "Dow still safely above 50,000 but early gains cut, Mattel and Lyft plunge",
        "description": "",
        "summary": "There were 130k new jobs added in January, well ahead of the consensus forecast of 55k",
        "pubDate": "2026-02-11T19:57:00Z",
        "displayTime": "2026-02-11T19:57:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/proactive_us_504/106f2bae61fdbfb4c49081e5e985e7da",
          "originalWidth": 993,
          "originalHeight": 720,
          "caption": "Dow still safely above 50,000 but early gains cut, Mattel and Lyft plunge",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/QMkub3q99LQksMqbMryNPg--~B/aD03MjA7dz05OTM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_us_504/106f2bae61fdbfb4c49081e5e985e7da.cf.webp",
              "width": 993,
              "height": 720,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pv5GksfrxlyMhCszLHoSeA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/proactive_us_504/106f2bae61fdbfb4c49081e5e985e7da.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Proactive",
          "url": "https://www.proactiveinvestors.com/"
        },
        "canonicalUrl": {
          "url": "https://www.proactiveinvestors.com/companies/news/1087191/nasdaq-and-dow-jones-seen-rising-ahead-of-delayed-jobs-report-1087191.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/nasdaq-dow-jones-seen-rising-125000364.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MAT"
            },
            {
              "symbol": "LYFT"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "NET"
            },
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T19:27:00+00:00",
    "headline": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, Micron, and More",
    "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
    "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
      "content": {
        "id": "d3c99806-d7e1-34e8-bfb0-e54d087fa7b0",
        "contentType": "STORY",
        "title": "These Stocks Are Today‚Äôs Movers: Shopify, Moderna, Robinhood, Unity, Vertiv, Generac, Beta Tech, Humana, Micron, and More",
        "description": "",
        "summary": "Robinhood reports weaker-than-expected growth in the fourth quarter while shares in Moderna tumble after the company says the Food and Drug Administration refuses to review a seasonal flu vaccine application.",
        "pubDate": "2026-02-11T19:27:00Z",
        "displayTime": "2026-02-11T19:27:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/d3c99806-d7e1-34e8-bfb0-e54d087fa7b0/these-stocks-are-today%E2%80%99s.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Uo8UTy_QlezfC1z9StNeHg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ONvzJWyntskVEcsn7C5YpA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/dfc369dfc75a1f0587c152e0f813ca6b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/stock-movers-93fe9143?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "HOOD"
            },
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "BTC-USD"
            },
            {
              "symbol": "SHOP"
            },
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "MSTR"
            },
            {
              "symbol": "VRT"
            },
            {
              "symbol": "HUM"
            },
            {
              "symbol": "MU"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]